NCT05878327|Completed
Loading search results
Sponsor study identifier
observational
15
1 country
3
Study Start
August 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2015
Actual (reported)Study Completion
June 2015
Actual (reported)A screening of patient histories at the clinics of Dermatology of the universities of Zurich, Basel and Bern is performed in order to identify patients with a history of Livedoid vasculopathy. Patients with a history of livedoid vasculopathy are asked to participate in the study. After reading the patient information and if the informed consent is signed patients are included in the study. Patients are questioned about their smoking history and blood is drawn in order to perform a screening for thrombophilia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2013
Date type not reportedThis date has not been verified as actual or estimated.
August 3, 2014
Actual (reported)June 2015
Actual (reported)June 2015
Actual (reported)May 26, 2023
Actual (reported)Smoking history: Patients will be asked if they currently smoke or if they are former smokers. If one of both items is yes, it means a positive answer.
The primary endpoint is the comparison of a positive smoking history and other cardiovascular risk factors of patients with livedoid vasculopathy with the Swiss general population.
22 months
Thrombophilia screening: the following parameters will be determined in every participant: Factor V Leiden, Prothrombin 20210; Protein C, Protein S, Antithrombin III, Beta 2 Glykoprotein 1, Lupus Antikoagulans
22 months
Patients with livedoid vasculopathy. Investigated by thrombophilia screening
No intervention. Blood is drawn for analysis.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients treated for livedoid vasculopathy at the clinics of Dermatology of the University hospitals of Zurich, Basel and Bern.
University hospital of Basel
Basel, 4013, Switzerland
University hospital of Bern
Bern, 3010, Switzerland
University hospital Zurich
Zurich, 8091, Switzerland
Blood samples for thrombophilia screen.
Juerg Hafner, Prof, MD
University Hospital Zurich, Dept. of Dermatology
15 participants (actual enrollment reported by the registry).
First Submitted
August 3, 2014
First Posted
May 26, 2023
Study Start
August 2013
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
June 2015
Actual (reported)Study Completion
June 2015
Actual (reported)Last Updated
May 26, 2023
Record last verified: 2023-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: